India · Delayed Price · Currency is INR Verve Therapeutics Statistics
Total Valuation
BOM:539005 has a market cap or net worth of INR 39.99 million. The enterprise value is -28.91 million.
| Market Cap | 39.99M |
| Enterprise Value | -28.91M |
Important Dates
The next estimated earnings date is Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:539005 has 3.00 million shares outstanding. The number of shares has increased by 0.46% in one year.
| Current Share Class | 3.00M |
| Shares Outstanding | 3.00M |
| Shares Change (YoY) | +0.46% |
| Shares Change (QoQ) | +0.71% |
| Owned by Insiders (%) | 81.06% |
| Owned by Institutions (%) | n/a |
| Float | 303,103 |
Valuation Ratios
The trailing PE ratio is 20.24.
| PE Ratio | 20.24 |
| Forward PE | n/a |
| PS Ratio | 6.35 |
| PB Ratio | 0.53 |
| P/TBV Ratio | 0.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -14.59 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -17.49 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -3.11% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 1.57M |
| Profits Per Employee | 495,250 |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:539005 has paid 652,700 in taxes.
| Income Tax | 652,700 |
| Effective Tax Rate | 24.78% |
Stock Price Statistics
The stock price has decreased by -21.12% in the last 52 weeks. The beta is -0.81, so BOM:539005's price volatility has been lower than the market average.
| Beta (5Y) | -0.81 |
| 52-Week Price Change | -21.12% |
| 50-Day Moving Average | 18.26 |
| 200-Day Moving Average | 33.71 |
| Relative Strength Index (RSI) | 31.79 |
| Average Volume (20 Days) | 59 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:539005 had revenue of INR 6.30 million and earned 1.98 million in profits. Earnings per share was 0.66.
| Revenue | 6.30M |
| Gross Profit | 4.92M |
| Operating Income | -3.85M |
| Pretax Income | 2.63M |
| Net Income | 1.98M |
| EBITDA | -2.99M |
| EBIT | -3.85M |
| Earnings Per Share (EPS) | 0.66 |
Balance Sheet
The company has 71.25 million in cash and 2.36 million in debt, giving a net cash position of 68.90 million or 22.97 per share.
| Cash & Cash Equivalents | 71.25M |
| Total Debt | 2.36M |
| Net Cash | 68.90M |
| Net Cash Per Share | 22.97 |
| Equity (Book Value) | 75.77M |
| Book Value Per Share | 25.65 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 78.08%, with operating and profit margins of -61.10% and 31.46%.
| Gross Margin | 78.08% |
| Operating Margin | -61.10% |
| Pretax Margin | 41.83% |
| Profit Margin | 31.46% |
| EBITDA Margin | -47.46% |
| EBIT Margin | -61.10% |
| FCF Margin | n/a |
Dividends & Yields
BOM:539005 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.46% |
| Shareholder Yield | n/a |
| Earnings Yield | 4.95% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |